UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 24, 2026
Sale
Calculated transaction value
$193.4K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 21, 2026
Public filing date
Aug 24, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$513.12
Aug 21, 2026
Close before public filing
$513.12
Aug 21, 2026
Return since public filing
-3.12%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 371 shares @ $521.28
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000126
Filing cohort
Transactions in this filing
Showing 15 of 17
Trades
17
Issuers
1
Estimated value
$6.21M
Buys / sales
0 / 15
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 21, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $609.62K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $139.25K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $321.52K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $871.78K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $399.69K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $558.03K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $434.47K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $228.81K |
| United Therapeutics Corp UTHR Current | Sale | Aug 21, 2026 | $193.4K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $349.41K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $238.25K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $327.72K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $123.47K |
| United Therapeutics Corp UTHR | Sale | Aug 21, 2026 | $23.69K |